Study of U3-1402 in EGFR Mutant NSCLC

Study of U3-1402  in EGFR Mutant NSCLC
Don Photo

Don
3 years 114 Views
Category:
Description:
Pasi A Jänne, MD, Director, Lowe Center for Thoracic Oncology, Belfer Center for Applied Cancer Science, Senior Physician, Professor of Medicine at Harvard Medical School discusses details on the study of U3-1402 in EGFR mutant non-small cell lung cancer (NSCLC).